novel transplant and post-transplant options in all
Published 2 years ago • 49 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
1:56
incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
-
2:38
optimizing outcomes with pre- and post-transplant interventions
-
5:32
the role of transplant for all in 2021
-
2:50
the impact of induction therapy on post-transplant outcomes in aml
-
1:05
novel car-ts to improve poor outcomes for patients with relapsed t-all post-transplant
-
1:53
how novel agents may eliminate the need for transplant in all
-
2:11
optimizing post-transplant outcomes
-
4:09
veno-occlusive disease as a post-transplant complication of hsct
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
3:41
managing post-transplant relapse in aml
-
1:37
transplantation: a holistic approach
-
3:09
post transplant complications: a focus on tma
-
1:26
novel transplant approaches in patients with aml
-
1:34
the value of car-t therapy and transplantation as treatment options for patients
-
2:37
allo-hsct for cll in the era of novel agents
-
0:42
haploidentical transplant in argentina
-
2:54
the management of post-transplant complications in hodgkin lymphoma